NKILT Therapeutics announces oral presentation featuring Chimeric ILT-Receptor (CIR™) engineered NK cells at the 65th ASH Annual Meeting and poster presentation at the 38th SITC Annual Meeting ...Middle East

PR Newswire - News
NKILT Therapeutics announces oral presentation featuring Chimeric ILT-Receptor (CIR™) engineered NK cells at the 65th ASH Annual Meeting and poster presentation at the 38th SITC Annual Meeting
HOUSTON, Nov. 3, 2023 /PRNewswire/ -- NKILT Therapeutics, Inc., a preclinical-stage cell therapy biotech company developing proprietary Chimeric ILT-Receptor (CIR™)–engineered natural killer (NK) cell therapies, announced today that preclinical data of the CIR™NK cells have been selected...

Hence then, the article about nkilt therapeutics announces oral presentation featuring chimeric ilt receptor cir engineered nk cells at the 65th ash annual meeting and poster presentation at the 38th sitc annual meeting was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( NKILT Therapeutics announces oral presentation featuring Chimeric ILT-Receptor (CIR™) engineered NK cells at the 65th ASH Annual Meeting and poster presentation at the 38th SITC Annual Meeting )

Apple Storegoogle play

Last updated :

Also on site :



Latest News